Özkaya Dilek, Doğru Atalay, Baykal Tuba
Department of Ophthalmology, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.
Department of Rheumatology, Süleyman Demirel University Faculty of Medicine, Isparta, Turkey.
Indian J Ophthalmol. 2024 Feb 1;72(2):206-210. doi: 10.4103/ijo.IJO_2024_22. Epub 2024 Jan 25.
To assess the corneal parameters in rheumatoid arthritis (RA) patients.
We enrolled 64 patients with RA (32 receiving biologic and 32 receiving conventional drugs) and 32 healthy subjects. Keratometric values (anterior flat [K1], steep [K2], and mean keratometry [Km]), corneal thickness from the pupil center (CCT), apex (ACT), and the thinnest point (TCT), and corneal volume (CV) were measured and compared between the groups.
K1, K2, and Km values were significantly higher in the RA group (P = 0.013, P = 0.048, P = 0.027, respectively). The means of CCT, ACT, TCT, and CV were significantly lower in RA patients (P < 0.001, P < 0.001, P < 0.001, P = 0.011, respectively). When we divided RA patients into two groups according to the treatment and compared them to controls, the differences in K1, CCT, ACT, TCT and CV were significant (P = 0.030, P = 0.005, P = 0.001, P = 0.001, P = 0.034, respectively). K1 and CV values of RA-biologic group were similar to the control group (P = 0.205 and P = 0.127, respectively).
Biologic agents contribute to the improvement of K1 and CV values in patients with RA.
评估类风湿关节炎(RA)患者的角膜参数。
我们纳入了64例RA患者(32例接受生物制剂治疗,32例接受传统药物治疗)以及32名健康受试者。测量并比较了两组之间的角膜曲率值(前表面平坦曲率[K1]、陡峭曲率[K2]和平均角膜曲率[Km])、瞳孔中心角膜厚度(CCT)、角膜顶点厚度(ACT)和最薄点角膜厚度(TCT)以及角膜体积(CV)。
RA组的K1、K2和Km值显著更高(分别为P = 0.013、P = 0.048、P = 0.027)。RA患者的CCT、ACT、TCT和CV平均值显著更低(分别为P < 0.001、P < 0.001、P < 0.001、P = 0.011)。当我们根据治疗方法将RA患者分为两组并与对照组进行比较时,K1、CCT、ACT、TCT和CV的差异具有统计学意义(分别为P = 0.030、P = 0.005、P = 0.001、P = 0.001、P = 0.034)。RA-生物制剂组的K1和CV值与对照组相似(分别为P = 0.205和P = 0.127)。
生物制剂有助于改善RA患者的K1和CV值。